• Skip to main content
  • Skip to primary sidebar

Tracking Health and Wellness Applications of Brain Science

Spanish
sb-logo-with-brain
  • Resources
    • Monthly eNewsletter
    • Solving the Brain Fitness Puzzle
    • The SharpBrains Guide to Brain Fitness
    • How to evaluate brain training claims
    • Resources at a Glance
  • Brain Teasers
    • Top 25 Brain Teasers & Games for Teens and Adults
    • Brain Teasers for each Cognitive Ability
    • More Mind Teasers & Games for Adults of any Age
  • Virtual Summits
    • 2019 SharpBrains Virtual Summit
    • Speaker Roster
    • Brainnovations Pitch Contest
    • 2017 SharpBrains Virtual Summit
    • 2016 SharpBrains Virtual Summit
    • 2015 SharpBrains Virtual Summit
    • 2014 SharpBrains Virtual Summit
  • Report: Pervasive Neurotechnology
  • Report: Digital Brain Health
  • About
    • Mission & Team
    • Endorsements
    • Public Speaking
    • In the News
    • Contact Us

drugs

First, do no harm? Common anticholinergic meds seen to increase dementia risk in older patients

June 26, 2019 by SharpBrains

Com­mon­ly Pre­scribed Meds Could Raise Demen­tia Risk (Web­MD):

“Doc­tors often pre­scribe anti­cholin­er­gic drugs for a vari­ety of ills. But a new study sug­gests they may increase the risk of demen­tia in old­er patients.

These med­i­cines include every­thing from Benadryl (diphen­hy­dramine) to cer­tain antipsy­chotics and Parkin­son’s meds. They’re used to treat a wide range of oth­er con­di­tions, includ­ing depres­sion, chron­ic obstruc­tive pul­monary dis­ease, over­ac­tive blad­der, aller­gies, and gas­troin­testi­nal disorders.

Anti­cholin­er­gic drugs help con­tract and relax mus­cles, and work by block­ing acetyl­choline, a chem­i­cal that trans­mits mes­sages in the ner­vous sys­tem … the new British study found that peo­ple aged 55 and old­er who took strong anti­cholin­er­gic med­ica­tions dai­ly for three years or more had a 50% increased risk of demen­tia [Read more…] about First, do no harm? Com­mon anti­cholin­er­gic meds seen to increase demen­tia risk in old­er patients

Share this:

  • Tweet
  • Email
  • Print
  • More
  • Share on Tumblr
  • Pock­et

Filed Under: Brain/ Mental Health Tagged With: anticholinergic, anticholinergic drugs, antipsychotics, Benadryl, dementi, dementia risk, diphenhydramine, drugs, middle-aged, older-people, Parkinson's meds

Does marijuana use cause schizophrenia? (unclear, but unlikely)

January 22, 2019 by SharpBrains

Does Mar­i­jua­na Use Cause Schiz­o­phre­nia? (The New York Times):

“… The con­cern is focused large­ly on the link between heavy usage and psy­chosis in young peo­ple. Doc­tors first sus­pect­ed a link some 70 years ago, and the evi­dence has only accu­mu­lat­ed since then. In a forth­com­ing book, “Tell Your Chil­dren,” Alex Beren­son, a for­mer Times reporter, argues that legal­iza­tion is putting a gen­er­a­tion at high­er risk of schiz­o­phre­nia and oth­er psy­chot­ic syn­dromes. Crit­ics, includ­ing lead­ing researchers, have called the argu­ment overblown, and unfaith­ful to the sci­ence [Read more…] about Does mar­i­jua­na use cause schiz­o­phre­nia? (unclear, but unlikely)

Share this:

  • Tweet
  • Email
  • Print
  • More
  • Share on Tumblr
  • Pock­et

Filed Under: Brain/ Mental Health Tagged With: cannabis, drugs, marijuana, psychosis, schizophrenia

Study: Common medication treatments for PTSD can increase the risk of developing dementia

May 22, 2017 by SharpBrains

—–

Drugs for PTSD linked to increased risk of demen­tia (The Phar­ma­ceu­ti­cal Journal):

“Cer­tain psy­chotrop­ic drugs used to treat post-trau­mat­ic stress dis­or­der (PTSD) increase the risk of devel­op­ing demen­tia, includ­ing in patients who do not have PTSD but take the drugs for oth­er con­di­tions, study results pub­lished in the Jour­nal of the Amer­i­can Geri­atrics Soci­ety [Read more…] about Study: Com­mon med­ica­tion treat­ments for PTSD can increase the risk of devel­op­ing dementia

Share this:

  • Tweet
  • Email
  • Print
  • More
  • Share on Tumblr
  • Pock­et

Filed Under: Brain/ Mental Health Tagged With: antidepressants, antipsychotics, benzodiazepines, dementia, dementia risk, drugs, geriatrics, medication-treatment, post-traumatic-stress-disorder, psychotropic, psychotropic medication, PTSD, selective serotonin reuptake inhibitors, SNRI

Therapy or antidepressants? Coming soon: Brain activity “fingerprints” to personalize depression treatments

January 9, 2015 by SharpBrains

mental health.

To Treat Depres­sion, Drugs or Ther­a­py? (The New York Times):

“Until recent­ly, many experts thought that your clin­i­cian could lit­er­al­ly pick any anti­de­pres­sant or type of psy­chother­a­py at ran­dom because, with a few clin­i­cal excep­tions, there was lit­tle evi­dence to favor one treat­ment over anoth­er for a giv­en patient [Read more…] about Ther­a­py or anti­de­pres­sants? Com­ing soon: Brain activ­i­ty “fin­ger­prints” to per­son­al­ize depres­sion treatments

Share this:

  • Tweet
  • Email
  • Print
  • More
  • Share on Tumblr
  • Pock­et

Filed Under: Brain/ Mental Health Tagged With: antidepressant, cognitive behavior therapy, cognitive-control, Decision-making, drugs, emotional self-awareness, insula, Mental-Health, personalized therapy, Psychotherapy, psychotropic drugs, therapy, treat depression

The New York Times starts to pay attention: Exercising The Mind to Treat Attention Deficits

May 13, 2014 by SharpBrains

mind_childExer­cis­ing The Mind to Treat Atten­tion Deficits (The New York Times):

“Poor plan­ning, wan­der­ing atten­tion and trou­ble inhibit­ing impuls­es all sig­ni­fy laps­es in cog­ni­tive con­trol. Now a grow­ing stream of research sug­gests that strength­en­ing this men­tal mus­cle, usu­al­ly with exer­cis­es in [Read more…] about The New York Times starts to pay atten­tion: Exer­cis­ing The Mind to Treat Atten­tion Deficits

Share this:

  • Tweet
  • Email
  • Print
  • More
  • Share on Tumblr
  • Pock­et

Filed Under: Attention & ADD/ADHD, Education & Lifelong Learning Tagged With: adhd, alternative ADHD treatments, attention deficit hyperactivity disorder, attention-deficit-disorder, brain-exercise, cognitive-control, drugs, mental-exercise, mind, mindfulness, treating ADHD

Upcoming Webinar: The Digital Brain Health & Training Market in 2014

February 24, 2014 by SharpBrains

Webinar digital brain health & trainingWhen: Thurs­day, March 13, 2014 from 12:30 PM to 2:00 PM (EDT)

Join this upcom­ing webi­nar, to be held dur­ing Brain Aware­ness Week 2014, to dis­cuss the lat­est mar­ket data and news in the dig­i­tal brain health and brain train­ing space, includ­ing Roset­ta Stone’s acqui­si­tion of Viv­i­ty Labs (devel­op­er of Fit Brains mobile cog­ni­tive games), Bay­er’s glob­al part­ner­ship with Cog­niFit [Read more…] about Upcom­ing Webi­nar: The Dig­i­tal Brain Health & Train­ing Mar­ket in 2014

Share this:

  • Tweet
  • Email
  • Print
  • More
  • Share on Tumblr
  • Pock­et

Filed Under: Brain/ Mental Health, Technology & Innovation Tagged With: ariel garten, Bayer, Brain-Training, Cogniciti, cognifit, cognitive self-assessment, cognitive-games, cognitive-health, Cognitive-Training, digital brain health, drugs, fit-brains, Interaxon, Michael Meagher, mobile cognitive games, multiple-sclerosis, Rosetta Stone, Tommy Sagroun, Vivity-Labs, webinar

Next Page »

Primary Sidebar

Top Articles on Brain Health and Neuroplasticity

  1. Can you grow your hippocampus? Yes. Here’s how, and why it matters
  2. How learning changes your brain
  3. To harness neuroplasticity, start with enthusiasm
  4. Three ways to protect your mental health during –and after– COVID-19
  5. Why you turn down the radio when you're lost
  6. Solving the Brain Fitness Puzzle Is the Key to Self-Empowered Aging
  7. Ten neu­rotech­nolo­gies about to trans­form brain enhance­ment & health
  8. Five reasons the future of brain enhancement is digital, pervasive and (hopefully) bright
  9. What Educators and Parents Should Know About Neuroplasticity and Dance
  10. The Ten Habits of Highly Effective Brains
  11. Six tips to build resilience and prevent brain-damaging stress
  12. Can brain training work? Yes, if it meets these 5 conditions
  13. What are cognitive abilities and how to boost them?
  14. Eight Tips To Remember What You Read
  15. Twenty Must-Know Facts to Harness Neuroplasticity and Improve Brain Health

Top 10 Brain Teasers and Illusions

  1. You think you know the colors? Try the Stroop Test
  2. Check out this brief attention experiment
  3. Test your stress level
  4. Guess: Are there more brain connections or leaves in the Amazon?
  5. Quick brain teasers to flex two key men­tal mus­cles
  6. Count the Fs in this sentence
  7. Can you iden­tify Apple’s logo?
  8. Ten classic optical illu­sions to trick your mind
  9. What do you see?
  10. Fun Mental Rotation challenge
  • Check our Top 25 Brain Teasers, Games and Illusions

Join 35,344 readers exploring, at no cost, the latest in neuroplasticity and brain health.

By subscribing you agree to receive our free, monthly eNewsletter. We don't rent or sell emails collected, and you may unsubscribe at any time.

IMPORTANT: Please check your inbox or spam folder in a couple minutes and confirm your subscription.

Get In Touch!

Contact Us

660 4th Street, Suite 205,
San Francisco, CA 94107 USA

About Us

SharpBrains is an independent market research firm tracking health and performance applications of brain science. We prepare general and tailored market reports, publish consumer guides, produce an annual global and virtual conference, and provide strategic advisory services.

© 2022 SharpBrains. All Rights Reserved - Privacy Policy